Hofseth BioCare ASA
HOFBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $468 | $683 | $1,209 | $2,388 |
| - Cash | $26 | $21 | $30 | $47 |
| + Debt | $171 | $281 | $104 | $139 |
| Enterprise Value | $613 | $942 | $1,283 | $2,480 |
| Revenue | $257 | $195 | $120 | $88 |
| % Growth | 32.1% | 61.8% | 37.5% | – |
| Gross Profit | $88 | $44 | $29 | $23 |
| % Margin | 34.1% | 22.7% | 23.7% | 26.4% |
| EBITDA | -$68 | -$63 | -$97 | -$88 |
| % Margin | -26.4% | -32.2% | -80.5% | -100.1% |
| Net Income | -$123 | -$107 | -$137 | -$126 |
| % Margin | -47.9% | -54.7% | -114.1% | -144.3% |
| EPS Diluted | -0.3 | -0.27 | -0.37 | -0.35 |
| % Growth | -11.1% | 27% | -5.7% | – |
| Operating Cash Flow | -$10 | $3 | -$45 | -$62 |
| Capital Expenditures | -$4 | -$14 | -$18 | -$38 |
| Free Cash Flow | -$14 | -$11 | -$63 | -$100 |